Abstract
In 1998, 539,000 percutaneous transluminal coronary angioplasty (PTCA) procedures were performed in the United States, an increase of 248% since 1987 [1]. Most of these interventions were followed by stenting. The advent of stents has revolutionized interventional cardiology; however, the Achilles’ heel of stenting is in-stent restenosis (ISR). In this chapter, the patterns, predictors, and treatment options for ISR are outlined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Referenzen
Heart and Stroke Statistical Update. In: American Heart Association; 2001.
Kimura T, Tamura T, Yokoi H, et al.: Long-term clinical and angiographic follow-up after placement of Palmaz-Schatz coronary stent: a single center experience.J Interv Cardiol 1994, 7:129–139.
Mehran R, Dangas G, Abizaid AS, et al.: Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999, 100:1872–1878.
Mintz GS, Popma JJ, Hong MK, et al.: Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 1996, 78:18–22.
van Beusekom HM, van der Giessen WJ, van Suylen R, et al.: Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993, 21:45–54.
Anderson PG, Bajaj RK, Baxley WA, et al.: Vascular pathology of balloon-expandable flexible coil stents in humans. J Am Coll Cardiol 1992, 19:372–381.
Gordon PC, Gibson CM, Cohen DJ, et al.: Mechanisms of restenosis and redilation within coronary stents—quantitative angiographic assessment. J Am Coll Cardiol 1993, 21:1166–1174.
Hoffmann R, Mintz GS, Dussaillant GR, et al.: Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996, 94:1247–1254.
Abizaid A, Kornowski R, Mintz GS, et al.: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998, 32:584–589.
Carrozza JP Jr, Kuntz RE, Fishman RF, et al.: Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993, 118:344–349.
Dauerman HL, Bairn DS, Cutlip DE, et ah: Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol 1998, 82:277–284.
Kereiakes D, Linnemeier TJ, Bairn DS, et al.: Usefulness of stent length in predicting in-stent restenosis (the Multi-Link stent trials). Am J Cardiol 2000, 86:336–341.
Lee SG, Lee CW, Hong MK, et al.: Predictors of diffuse-type in-stent restenosis after coronary stent implantation. Catheter Cardiovasc Interv 1999,47:406–409,410.
Sheiban I, Leonardo F, Rosano GM, et al.: Predictors of long-term clinical outcome in patients undergoing multiple vessel stenting for coronary artery disease. Ital Heart J 2000, 1:480–486.
Kastrati A, Schomig A, Elezi S, et al.: Predictive factors of restenosis after coronary stent placement.J Am Coll Cardiol 1997, 30:1428–1436.
Gruberg L, Hong MK, Mintz GS, et al.: Optimally deployed stents in the treatment of restenotic versus de novo lesions. Am J Cardiol 2000, 85:333–337.
Klugherz BD, Meneveau NF, Kolansky DM, et al.: Predictors of clinical outcome following percutaneous intervention for in-stent restenosis. Am J Cardiol 2000, 85:1427–1431.
Kasaoka S, Tobis JM, Akiyama T, et al.: Angiographic and intravascular ultrasound predictors of in-stent restenosis.J Am Coll Cardiol 1998, 32:1630–1635.
Gupta A, Kerkar PG, Vajifdar BU, et al.: Restenosis after coronary stenting— incidence and predictors.J Assoc Physicians India 2001, 49:336–342.
Ribichini F, Steffenino G, Dellavalle A, et al.: Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998, 97:147–154.
Mintz GS, Popma JJ, Pichard AD, et al.: Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol 1996, 27:1678–1687.
Brito FSJr, Caixeta AM, Rati MA, et al.: Patient-related and angiographic predictors of restenosis after excimer laser coronary angioplasty.J Invasive Cardiol 1998, 10:162–168.
Ellis SG, Savage M, Fischman D, et al.: Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992, 86:1836–1844.
Kini A, Marmur JD, Dangas G, et al.: Angiographic patterns of in-stent restenosis and implications on subsequent revascularization. Catheter Cardiovasc Interv 2000, 49:23–29.
Choussat R, Klersy C, Black AJ, et al.: Long-term (8 years or longer) outcome after Palmaz-Schatz stent implantation. Am J Cardiol 2001, 88:10–16.
Kornowski R, Mehran R, Satler LF, et al.: Procedural results and late clinical outcomes following multivessel coronary stenting.J Am Coll Cardiol 1999, 33:420–426.
DeServi S, Mariani G, Bossi I, et al.: One-year outcome in multivessel coronary disease patients undergoing coronary stenting. Catheter Cardiovasc Interv 1999, 48:343–349.
Hoffmann R, Mintz GS, Mehran R, et al.: Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol 1998, 31:43–49.
Finci L, Ferraro M, Nishida T, et al.: Coronary stenting beyond standard indications. Immediate and follow-up results. Ital Heart J 2000, 1:739–748.
Sheiban I, Albiero R, Marsico F, et al.: Immediate and long-term results of “T” stenting for bifurcation coronary lesions. Am J Cardiol 2000, 85:1141–1144, A9.
Bauters C, Hubert E, Prat A, et al.: Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998, 31:1291–1298.
Jeong MH, Kim SH, Ahn YK, et al.: Predictive factors for the second restenosis after coronary interventions. Catheter Cardiovasc Interv 2000, 50:34–39.
Kastrati A, Schomig A, Elezi S, et al.: Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999, 100:1285–1290.
Kastrati A, Schomig A, Elezi S, et al.: Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999, 100:1285–1290.
Kastrati A, Dirschinger J, Boekstegers P, et al.: Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1, 147 unselected patients. Catheter Cardiovasc Interv 2000, 50:290–297.
Kobayashi Y, DeGregorio J, Kobayashi N, et al.: Stented segment length as an independent predictor of restenosis.J Am Coll Cardiol 1999, 34:651–659.
Kornowski R, Bhargava B, Fuchs S, et al.: Procedural results and late clinical outcomes after percutaneous interventions using long (25 mm or greater) versus short (20 mm or less) stents.J Am Coll Cardiol 2000, 35:612–618.
Kastrati A, Elezi S, Dirschinger J, et al.: Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999, 83:1617–1622.
Kastrati A, Schomig A, Dirschinger J, et al.: A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation 2000, 102:2593–2598.
Kastrati A, Mehilli J, Dirschinger J, et al.: Restenosis after coronary placement of various stent types. Am J Cardiol 2001, 87:34–39.
Park SW, Park HK, Hong MK, et al.: Comparison of slotted tube versus coil stent implantation for ostial left anterior descending coronary artery stenosis: initial and late clinical outcomes.J Korean Med Sci 1998, 13:483–487.
Carrozza JP Jr, Hosley SE, Cohen DJ, et al.: In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design. Circulation 1999, 100:756–760.
Ho DS, Liu MW, Iyer S, et al.: Sizing the Gianturco-Roubin coronary flexible coil stent. Cathet Cardiovasc Diagn 1994, 32:242–248.
Vrints CJ, Cools F, Bosmans J, et al.: Acute luminal gain after stenting: comparison of Gianturco-Roubin and Palmaz-Schatz stents.J Invasive Cardiol 1996, 8:135–143.
Maclsaac AI, Ellis SG, Muller DW, et al.: Comparison of three coronary stents: clinical and angiographic outcome after elective placement in 134 consecutive patients. Cathet Cardiovasc Diagn 1994, 33:199–204.
Silber S, Seidel N, Muehling H, et al.: In-stent restenosis using newer stent designs available in Germany (abstract). J Am Coll Cardiol 1998, 1033–1106.
Yokoi H, Kimura T, Hamasaki N, et al.: Coronary stenting for STRESS/ BENESTENT equivalent lesions: Comparison of four different types of stent. J Am Coll Cardiol 1998, 1137–1164.
Kastrati A, Schomig A, Dirschinger J, et al.: Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000, 101:2478–2483.
Kastrati A, Mehilli J, Dirschinger J, et al.: Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001, 103:2816–2821.
Kuntz RE, Gibson CM, Nobuyoshi M, et al.: Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993, 21:15–25.
Hong MK, Park SW, Mintz GS, et al.: Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting. Am J Cardiol 2000, 85:441–45.
Hasdai D, Garratt KN, Grill DE, et al.: Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997, 336:755–761.
Jolly N, Ellis SG, Franco I, et al.: Coronary artery stent restenosis responds favorably to repeat interventions. Am J Cardiol 1999, 83:1565–1568, A7.
Koch W, Kastrati A, Mehilli J, et al.: Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 2000, 102:197–202.
Kastrati A, Schomig A, Seyfarth M, et al.: PIA polymorphism of platelet glycoprotein Ilia and risk of restenosis after coronary stent placement. Circulation 1999, 99:1005–1010.
Hoffmann R, Mintz GS: Coronary in-stent restenosis—predictors, treatment and prevention. Eur Heart J 2000, 21:1739–1749.
Carrozza JP, Jr.: In-stent restenosis: should an old device treat a new problem? J Am Coll Cardiol 2000, 35:1577–1579.
Bairn DS, Levine MJ, Leon MB, et al.: Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience). Am J Cardiol 1993, 71:364–366.
Reimers B, Moussa I, Akiyama T, et al.: Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis.J Am Coll Cardiol 1997, 30(1):186–192.
Bossi I, Klersy C, Black AJ, et al.: In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 2000, 35:1569–1576.
Mehran R, Mintz GS, Popma JJ, et al.: Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 1996, 78:618–622.
Eltchaninoff H, Koning R, Tron C, et al.: Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998, 32(4):980–984.
Mehran R, Dangas G, Abizaid A, et al.: Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. Am Heart J 2001, 141:610–614.
Shiran A, Mintz GS, Waksman R, et al.: Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study. Circulation 1998, 98:200–203.
Alfonso F, Cequier A, Zueco J, et al.: Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis. Am J Cardiol 2000, 85:327–332.
Alfonso F: RIBS: Repeat stenting shows benefits in large but not small vessels. In: American College of Cardiology 50th Annual Scientific Sessions; 2000; Orlando, FL.
Radke PW, Klues HG, Haager PK, et al.: Mechanisms of acute lumen gain and recurrent restenosis after rotational atherectomy of diffuse in-stent restenosis: a quantitative angiographic and intravascular ultrasound study.J Am Coll Cardiol 1999, 34:33–39.
Mehran R, Dangas G, Mintz GS, et al.: In-stent restenosis: “The great equalizer” —8 disappointing clinical outcomes with all interventional strategies. In: American College of Cardiology 48th Annual Scientific Session; 1999; New Orleans, LA. Abstract 63A.
Sharma SK, Kini A, King T, et al.: Randomized trial of rotational atherectomy versus balloon angioplasty for diffuse in-stent restenosis. Final results (abstract). Circulation 2000, 102:11–730.
Ferguson JJ: Meeting highlights: highlights of the 22nd Congress of the European Society of Cardiology. Circulation 2001, 103:E41-E45.
Kobayashi Y, De Gregorio J, Kobayashi N, et al.: Lower restenosis rate with stenting following aggressive versus less aggressive rotational atherectomy. Catheter Cardiovasc Interv 1999, 46:406–414.
Strauss BH, Umans VA, van Suylen RJ, et al.: Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results. J Am Coll Cardiol 1992, 20:1465–1473.
Mahdi NA, Pathan AZ, Harrell L, et al.: Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. Am J Cardiol 1998, 82:1345–1351.
Meyer T, Schmidt T, Buchwald A, et al.: Stent wire cutting during coronary directional atherectomy. Clinical Cardiology 1993, 16:450–452.
Mehran R, Mintz GS, Satler LF, et al.: Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation 1997, 96:2183–2189.
Giri S, Ito S, Lansky AJ, et al.: Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv 2001, 52:24–34.
Mehran R, Dangas G, Mintz GS, et al.: Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. Circulation 2000, 101:2484–2489.
Albiero R, Nishida T, Karvouni E, et al.: Cutting balloon angioplasty for the treatment of in-stent restenosis. Catheter Cardiovasc Interv 2000, 50:452–459.
Freitas Junior JO, Berti SL, Bonfa JG, et al.: Cutting balloon angioplasty for intrastent restenosis treatment. Arq Bras Cardiol 1999, 72:615–620.
Molstad P, Myreng Y, Golf S, et al.: The Barath Cutting Balloon versus conventional angioplasty. A randomized study comparing acute success rate and frequency of late restenosis. Scand Cardiovasc J 1998, 32:79–85.
Muramatsu T, Tsukahara R, Ho M, et al.: Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation.J Invasive Cardiol 2001, 13:439–444.
Chevalier B, Royer T, Guyon P, et al.: Treatment of in-stent restenosis: Short and midterm results of a pilot study between balloon and cutting balloon (abstract). J Am Coll Cardiol 1999, 33:63A.
Mizobe M, Oohata K, Osada T: The efficacy of cutting balloon for in-stent restenosis: Compared with conventional balloon angioplasty (abstract). Circulation 1999, 100:1–308.
Adamian M, Marsico F, Briguori C, et al.: Cutting balloon for treatment of in-stent restenosis: A matched comparison with conventional angioplasty and rotational atherectomy (abstract). Circulation 1999, 100:1–305.
Adamian M, Colombo A, Briguori C, et al.: Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty.J Am Coll Cardiol 2001, 38:672–679.
Lauer B, Schmidt E, Stellbring S, et al.: Cutting balloon angioplasty for treatment of in-stent restenosis (abstract). Circulation 2000, 102:11–365.
Waksman R, Bhargava B, White L, et al.: Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000, 101:1895–1898.
Waksman R, White RL, Chan RC, et al.: Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000, 101:2165–2171.
Verin V, Popowski Y, de Bruyne B, et al.: Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001, 344:243–249.
Teirstein PS, Massullo V, Jani S, et al.: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997, 336:1697–1703.
Condado JA, Waksman R, Gurdiel O, et al.: Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997, 96:727–732.
Malhotra S, Teirstein PS: The SCRIPPS trial—catheter-based radiotherapy to inhibit coronary restenosis. J Invasive Cardiol 2000, 12:330–332.
Waksman R: Intracoronary gamma radiation for diffuse in-stent restenosis. J Am Coll Cardiol 2000, 36:315–316.
Leon MB, Teirstein PS, Moses JW, et al.: Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001, 344:250–256.
Teirstein P, Moses JW, Casterella PJ, et al.: Late thrombosis after coronary radiation may be eliminated by longer antiplatelet therapy and reduced stenting: The Scripps III results. J Am Coll Cardiol 2001, 37:60A.
King SB3rd, Williams DO, Chougule P, et al.: Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998, 97:2025–2030.
97.Raizner AE, Oesterle SN, Waksman R, et al.: Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000, 102:951–958.
Verin V, Urban P, Popowski Y, et al.: Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation 1997, 95:1138–1144.
99.Kleiman NS, Califf RM: Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology.J Am Coll Cardiol 2000, 36:310–325.
Loskey W: Late clinical and angiographic outcomes after use of Sr-90 beta radiation for the treatment of in-stent restenosis from the START 90 (Stents and Radiation Therapy 90) trial. Paper presented at: Annual Meeting of the American Heart Association; November 12–15, 2000; New Orleans, LA.
Sianos G, Kay IP, Costa MA, et al.: Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In Europe. J Am Coll Cardiol 2001, 38:415–420.
Sousa JE, Costa MA, Abizaid A, et al.: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001, 103:192–195.
Capper EA, Roshak AK, Bolognese BJ, et al.: Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis.J Pharmacol Exp Ther 2000, 295:1061–1069.
Holmes D, Fitzgerald P, Goldberg S, et al.: The PRESTO (prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J 2000, 139:23–31.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Denktas, A.E., Mathew, V. (2003). In-stent Restenosis. In: Holmes, D.R., Mathew, V. (eds) Atlas of Interventional Cardiology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4613-1091-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1091-4_6
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-0808-0
Online ISBN: 978-1-4613-1091-4
eBook Packages: Springer Book Archive